in vivo ≠ in vitro [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2022-07-25 11:56 (132 d 03:25 ago) – Posting: # 23167
Views: 676

Hi Mithu,

❝ Is it advisable to have little large sample size …


Larger than what?

❝ … for molecules falls under BCS Class II and IV? especially when routine 2WC design is selected?


Only in a few cases of BCS class II drugs (under certain conditions) there is an in vivo in vitro correlation. For BCS class IV drugs never. You plan the study always based on the in vivo variability and T/R-ratio for a desired power. In other words, BCS does not play any role.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,428 posts in 4,694 threads, 1,598 registered users;
22 visitors (1 registered, 21 guests [including 9 identified bots]).
Forum time: 14:21 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5